Back to top

Longevity Biotech Surges as $72.6B Market Forecast Sparks Investment Rush

Issued on behalf of Avant Technologies Inc. VANCOUVER – Baystreet.ca News Commentary – The longevity and cell therapy sector has captured Wall Street's attention as market projections ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Autolus Therapeutics PLC Sponsored ADR (AUTL)

Editas Medicine, Inc. (EDIT)

Xencor, Inc. (XNCR)